Seeking Alpha

Salix Pharmaceuticals (SLXP -4.8%) slides after Auriga downgrades the stock to Hold from Buy and...

Salix Pharmaceuticals (SLXP -4.8%) slides after Auriga downgrades the stock to Hold from Buy and lowers its price target to $51 from $54. The firm says SLXP shares appear to have already priced in upside from the potential approval of developmental drugs Relistor and Crofelemer. Auriga had upgraded shares to Buy only six weeks ago.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)